Assessment of right ventricular dysfunction in breast cancer patients undergoing anthracycline and trastuzumab treatment

Back

ESC Professional Premium Access

Assessment of right ventricular dysfunction in breast cancer patients undergoing anthracycline and trastuzumab treatment

Session: Cardio-oncology: treatments and outcomes

Topic: Cardio-Oncology

Speaker: Doctor M. Santa Ana Bayona (Mexico City, MX)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Maria Jose Santa Ana Bayona

Mexico City (Mexico)

1 presentation

0 follower

9 more presentations in this session

The impact of peptide receptor radionucleotide therapy with Lutetium-177 DOTATATE on cardiac metastases in neuroendocrine tumors

Speaker: Associate Professor C. Ayoub (Scottsdale, US)

The predictive value of coronary artery calcium deposit for cardiovascular events in patients treated with immune checkpoint inhibitor therapy

Speaker: Doctor M. Slieman (Tel Aviv, IL)

Long term risk of heart failure in adult cancer survivors: a systematic review and meta-analysis

Speaker: Doctor J. Wong (Melbourne, AU)

Incidence of acute cardiovascular hospitalizations and association with hemodynamic biomarkers in cancer patients treated with Immune Checkpoint Inhibitor therapy

Speaker: Doctor C. Mann (Vienna, AT)

Association between PCSK9 inhibitor with cause-specific morality amongst cancer survivors

Speaker: Professor T. Liu (Tianjin, CN)

Access the full session

Cardio-oncology: treatments and outcomes

Speakers: Doctor M. Santa Ana Bayona, Associate Professor C. Ayoub, Doctor M. Slieman, Doctor J. Wong, Doctor C. Mann...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources